1
项与 Anti-HBV therapy(Apeloa) 相关的临床试验Observational, Post-marketing Renal Safety Surveillance Registry in Subjects With Chronic Hepatitis B (HBV) Infection With Decompensated Liver Disease Receiving Nucleotide/Side Therapy
This registry will remain open for approximately 5 years (4 years of enrollment + 1 year of follow up). Subjects will be followed until Orthotopic Liver Transplant (OLT), resolution of liver decompensation, death, or conclusion of the registry.
100 项与 Anti-HBV therapy(Apeloa) 相关的临床结果
100 项与 Anti-HBV therapy(Apeloa) 相关的转化医学
100 项与 Anti-HBV therapy(Apeloa) 相关的专利(医药)
100 项与 Anti-HBV therapy(Apeloa) 相关的药物交易